HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Effect of dorzolamide timolol combination versus timolol 0.5% on ocular bloodflow in patients with primary open-angle glaucoma.

AbstractPURPOSE:
Addition of dorzolamide to timolol in primary open-angle glaucoma shows augmented reduction of intraocular pressure. It is unknown as yet if addition of dorzolamide will alter hemodynamics.
METHODS:
Fifteen patients with primary open-angle glaucoma were placed on a medication-dependent 1-week to 4-week washout that included maintenance on timolol. After washout, baseline measurements were taken (timolol). They were studied after a month on timolol or dorzolamide-timolol (Cosopt; Merck, Inc, Whitehouse Station, New Jersey), with the second drug preceded by another month of timolol maintenance and second baseline measurements. At each visit, visual function, intraocular pressure, and ocular hemodynamics were monitored, including indocyanine green and fluorescein angiography and color Doppler imaging.
RESULTS:
Cosopt significantly reduced intraocular pressure (14.7 to 13.4 mm Hg, P <.05) and increased arteriovenous passage time (superior temporal artery) of fluorescein dye (2.13 to 1.76 seconds, P =.01) but had no effect on visual function.
CONCLUSIONS:
When compared with timolol in primary open-angle glaucoma, Cosopt augments ocular tension reduction and reduces the amount of time required for blood to pass through the superior retinal vasculature.
AuthorsA Harris, C P Jonescu-Cuypers, L Kagemann, E A Nowacki, H Garzozi, C Cole, B Martin
JournalAmerican journal of ophthalmology (Am J Ophthalmol) Vol. 132 Issue 4 Pg. 490-5 (Oct 2001) ISSN: 0002-9394 [Print] United States
PMID11589868 (Publication Type: Clinical Trial, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Adrenergic beta-Antagonists
  • Antihypertensive Agents
  • Ophthalmic Solutions
  • Sulfonamides
  • Thiophenes
  • Timolol
  • dorzolamide
  • Indocyanine Green
Topics
  • Adrenergic beta-Antagonists (administration & dosage, therapeutic use)
  • Antihypertensive Agents (administration & dosage, therapeutic use)
  • Blood Flow Velocity
  • Ciliary Arteries (diagnostic imaging, physiopathology)
  • Cross-Over Studies
  • Double-Blind Method
  • Drug Therapy, Combination
  • Eye (blood supply)
  • Fluorescein Angiography
  • Glaucoma, Open-Angle (drug therapy, physiopathology)
  • Humans
  • Indocyanine Green
  • Intraocular Pressure (drug effects)
  • Laser-Doppler Flowmetry
  • Ophthalmic Artery (diagnostic imaging, physiopathology)
  • Ophthalmic Solutions
  • Ophthalmoscopy
  • Regional Blood Flow
  • Retinal Artery (diagnostic imaging, physiopathology)
  • Sulfonamides (administration & dosage, therapeutic use)
  • Thiophenes (administration & dosage, therapeutic use)
  • Timolol (administration & dosage, therapeutic use)
  • Tonometry, Ocular
  • Ultrasonography
  • Visual Acuity

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: